Advanced Search
ZHANG Jing-song, YANG Shu-hua, CHEN Shu-wei, WU Qiang. Expression of Skp2 and p27 in Osteosarcoma and Their Clinical Significance[J]. Cancer Research on Prevention and Treatment, 2007, 34(03): 189-191. DOI: 10.3971/j.issn.1000-8578.2399
Citation: ZHANG Jing-song, YANG Shu-hua, CHEN Shu-wei, WU Qiang. Expression of Skp2 and p27 in Osteosarcoma and Their Clinical Significance[J]. Cancer Research on Prevention and Treatment, 2007, 34(03): 189-191. DOI: 10.3971/j.issn.1000-8578.2399

Expression of Skp2 and p27 in Osteosarcoma and Their Clinical Significance

More Information
  • Received Date: January 25, 2006
  • Revised Date: April 05, 2006
  • Objective  To investigate the expression of Skp2 and p27 and their association with clinical, histologic characteristics in osteosarcoma, the correlation between expression of Skp2 and p27 in osteosarcoma. Methods  Skp2 protein and p27 protein were examined by using immunohistochemical SP staining method in 48 cases of osteosarcoma and 16 cases of osteochondroma. Results  Negative expression of Skp2 was detected in all osteochondroma. In contrast, it was detected in 43. 75 %(21/ 48) of osteosarcoma. Positive expression of Skp2 was detected significantly more frequently in osteosarcoma than that of osteochondroma. Skp2 protein expression in osteosarcoma was positively associated with the clinical stage and differentiation. The positive rate of p27 protein in osteochondroma and osteosarcoma were 75 %(12/16) 、47. 92 % (23/ 48), significant difference was found between these two groups. p27 protein expression in osteosarcoma was negatively associated with the clinical stage and differentiation. Skp2 was inversely associated with expression of p27 in osteosarcoma. Conclusion  Skp2 expression might play an important role in the development and progression of osteosarcoma via cyclin-depended kinase inhibitor p27 proteolysis, and the combined examination of Skp2 and p27 expression might be a guide for early diagnosis and a determinant of malignancy and prognosis of osteosarcoma.
  • Related Articles

    [1]GAO Hongyan, GUO Jie, WU Fangxiong, LIU Fengrui, WANG Li. Mechanism of miRNA-451 Regulating Resistance of Gastric Cancer Cells to 5-Fu Through MRP[J]. Cancer Research on Prevention and Treatment, 2019, 46(12): 1073-1077. DOI: 10.3971/j.issn.1000-8578.2019.19.0618
    [2]YANG Yuanyuan, LU Yang, ZHANG Xiaolong, ZHANG Qing, LI Zhenzhen, ZHANG Yanjun. Inhibition Effect of Ad-IL24 Combined with Low Dose of 5-Fu on Hepatocarcinoma Cells HepG2 and Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2016, 43(12): 1030-1034. DOI: 10.3971/j.issn.1000-8578.2016.12.004
    [3]FAN Xulong, WU Aiguo, ZHU Dajiang, JIAO Qingli, ZHENG Linhai, SHAO Guoli, WANG Mengchuan, JI Shufeng. Beclin 1 Protein Enhances Sensitivity of Triple-negative Breast Cancer Cell Line BT-549 to 5-Fu by Promoting Cell Apoptosis[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 436-441. DOI: 10.3971/j.issn.1000-8578.2015.05.003
    [4]WEI Shu-zhen, ZHANG Chuang, SHA Xiao-feng, ZHANG Jiao. Effect of Rotary Magnetic Field Combining 5-fluorouracil on Cell Cycle and Apoptosis in SP2/0 Cell Line[J]. Cancer Research on Prevention and Treatment, 2010, 37(12): 1367-1369. DOI: 10.3971/j.issn.1000-8578.2010.12.009
    [5]SHI Xiao-yu, HAN Yu, ZHOU Jian-hua, WANG Li-Jie, BAI Yu-xian. Effect Contrasting of Nedaplatin plus 5-Fu and Cisplatin plus 5-Fu in Treatment with Advanced Esophageal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2008, 35(05): 358-360. DOI: 10.3971/j.issn.1000-8578.2345
    [6]FAN Hai-ning, HUANG Tao. Antisense RNA of survivin Enhances the Sensitivity of PANC-1 Cell to 5-Fu[J]. Cancer Research on Prevention and Treatment, 2005, 32(05): 279-281. DOI: 10.3971/j.issn.1000-8578.1273
    [7]CHEN Xin, LIN Wen bo, SHEN You zhu. The Influence of Thymidylate Synthase (TS) in Colon Carcinoma used 5-Fu Cure Prospective Study[J]. Cancer Research on Prevention and Treatment, 2004, 31(08): 480-481. DOI: 10.3971/j.issn.1000-8578.3182
    [8]ZHOU Jian-hua, ZHANG Li-chen, LU Hai-bo, et al. Short-term response of continuous infusion of 5-Fu in advanced gastric carcinoma[J]. Cancer Research on Prevention and Treatment, 2003, 30(06): 500-501. DOI: 10.3971/j.issn.1000-8578.2922
    [9]LIANG Qi-lian, PAN Da-chao, ZHANG Ying, et al, . Clinical study of the effect of calcium folinate,5-Fluorouracil bolus and continuous infusion combined with AM regimen in the treatment of advanced primary hepatocellular carcinoma[J]. Cancer Research on Prevention and Treatment, 2003, 30(05): 417-418. DOI: 10.3971/j.issn.1000-8578.2114
    [10]Wu Hui, Huang Xuezhen, Xie Xianhe. Estimating the Short-term Effect of CF. 5-Fu and DDP in Treating Advanced Nasopharygeal Carcinona[J]. Cancer Research on Prevention and Treatment, 1999, 26(3): 217-218.

Catalog

    WU Qiang

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (2792) PDF downloads (657) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return